TY - JOUR
T1 - Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients
T2 - the ECHOVID-19 study
AU - Lassen, Mats Christian Højbjerg
AU - Skaarup, Kristoffer Grundtvig
AU - Lind, Jannie Nørgaard
AU - Alhakak, Alia Saed
AU - Sengeløv, Morten
AU - Nielsen, Anne Bjerg
AU - Espersen, Caroline
AU - Ravnkilde, Kirstine
AU - Hauser, Raphael
AU - Schöps, Liv Borum
AU - Holt, Eva
AU - Johansen, Niklas Dyrby
AU - Modin, Daniel
AU - Djernæs, Kasper
AU - Graff, Claus
AU - Bundgaard, Henning
AU - Hassager, Christian
AU - Jabbari, Reza
AU - Carlsen, Jørn
AU - Lebech, Anne-Mette
AU - Kirk, Ole
AU - Bodtger, Uffe
AU - Lindholm, Matias Greve
AU - Joseph, Gowsini
AU - Wiese, Lothar
AU - Schiødt, Frank Vinholt
AU - Kristiansen, Ole Peter
AU - Walsted, Emil Schwarz
AU - Nielsen, Olav Wendelboe
AU - Madsen, Birgitte Lindegaard
AU - Tønder, Niels
AU - Benfield, Thomas
AU - Jeschke, Klaus Nielsen
AU - Ulrik, Charlotte Suppli
AU - Knop, Filip
AU - Lamberts, Morten
AU - Sivapalan, Pradeesh
AU - Gislason, Gunnar
AU - Marott, Jacob Louis
AU - Møgelvang, Rasmus
AU - Jensen, Gorm
AU - Schnohr, Peter
AU - Søgaard, Peter
AU - Solomon, Scott D.
AU - Iversen, Kasper
AU - Jensen, Jens Ulrik Stæhr
AU - Schou, Morten
AU - Biering-Sørensen, Tor
PY - 2020
Y1 - 2020
N2 - Aims The present study had two aims: (i) compare echocardiographic parameters in COVID-19 patients with matched controls and (2) assess the prognostic value of measures of left (LV) and right ventricular (RV) function in relation to COVID-19 related death.Methods and results In this prospective multicentre cohort study, 214 consecutive hospitalized COVID-19 patients underwent an echocardiographic examination (by pre-determined research protocol). All participants were successfully matched 1:1 with controls from the general population on age, sex, and hypertension. Mean age of the study sample was 69 years, and 55% were male participants. LV and RV systolic function was significantly reduced in COVID-19 cases as assessed by global longitudinal strain (GLS) (16.4% +/- 4.3 vs. 18.5% +/- 3.0,P <0.001), tricuspid annular plane systolic excursion (TAPSE) (2.0 +/- 0.4 vs. 2.6 +/- 0.5,P <0.001), and RV strain (19.8 +/- 5.9 vs. 24.2 +/- 6.5,P = 0.004). All parameters remained significantly reduced after adjusting for important cardiac risk factors. During follow-up (median: 40 days), 25 COVID-19 cases died. In multivariable Cox regression reduced TAPSE [hazard ratio (HR) = 1.18, 95% confidence interval (CI) [1.07-1.31],P = 0.002, per 1 mm decrease], RV strain (HR = 1.64, 95%CI[1.02;2.66],P = 0.043, per 1% decrease) and GLS (HR = 1.20, 95%CI[1.07-1.35],P = 0.002, per 1% decrease) were significantly associated with COVID-19-related death. TAPSE and GLS remained significantly associated with the outcome after restricting the analysis to patients without prevalent heart disease.Conclusions RV and LV function are significantly impaired in hospitalized COVID-19 patients compared with matched controls. Furthermore, reduced TAPSE and GLS are independently associated with COVID-19-related death.
AB - Aims The present study had two aims: (i) compare echocardiographic parameters in COVID-19 patients with matched controls and (2) assess the prognostic value of measures of left (LV) and right ventricular (RV) function in relation to COVID-19 related death.Methods and results In this prospective multicentre cohort study, 214 consecutive hospitalized COVID-19 patients underwent an echocardiographic examination (by pre-determined research protocol). All participants were successfully matched 1:1 with controls from the general population on age, sex, and hypertension. Mean age of the study sample was 69 years, and 55% were male participants. LV and RV systolic function was significantly reduced in COVID-19 cases as assessed by global longitudinal strain (GLS) (16.4% +/- 4.3 vs. 18.5% +/- 3.0,P <0.001), tricuspid annular plane systolic excursion (TAPSE) (2.0 +/- 0.4 vs. 2.6 +/- 0.5,P <0.001), and RV strain (19.8 +/- 5.9 vs. 24.2 +/- 6.5,P = 0.004). All parameters remained significantly reduced after adjusting for important cardiac risk factors. During follow-up (median: 40 days), 25 COVID-19 cases died. In multivariable Cox regression reduced TAPSE [hazard ratio (HR) = 1.18, 95% confidence interval (CI) [1.07-1.31],P = 0.002, per 1 mm decrease], RV strain (HR = 1.64, 95%CI[1.02;2.66],P = 0.043, per 1% decrease) and GLS (HR = 1.20, 95%CI[1.07-1.35],P = 0.002, per 1% decrease) were significantly associated with COVID-19-related death. TAPSE and GLS remained significantly associated with the outcome after restricting the analysis to patients without prevalent heart disease.Conclusions RV and LV function are significantly impaired in hospitalized COVID-19 patients compared with matched controls. Furthermore, reduced TAPSE and GLS are independently associated with COVID-19-related death.
KW - COVID-19
KW - Echocardiography
KW - Global longitudinal strain
KW - Right ventricular strain
KW - SARS-CoV-2
KW - CARDIAC CHAMBER QUANTIFICATION
KW - EUROPEAN ASSOCIATION
KW - AMERICAN SOCIETY
KW - RECOMMENDATIONS
KW - UPDATE
KW - ADULTS
KW - STRAIN
KW - HEART
KW - GUIDELINES
U2 - 10.1002/ehf2.13044
DO - 10.1002/ehf2.13044
M3 - Journal article
C2 - 33089972
VL - 7
SP - 4189
EP - 4197
JO - E S C Heart Failure
JF - E S C Heart Failure
SN - 2055-5822
IS - 6
ER -